CEIDR and HPRU EZI COVID-19 research programme

The University of Liverpool (UoL), Liverpool School of Tropical Medicine (LSTM) and the NHS, represented by Liverpool Health Partners (LHP), have united to redirect the majority of Liverpool’s research efforts to COVID-19. Research programmes are designed to have immediate benefits for public health. This programme is supported by approximately £1 million in pump priming from the University of Liverpool and the Liverpool School of Tropical Medicine and the efforts of over 200 researchers, underpinned by equipment and laboratory space across the Liverpool City Region.

The Health Protection Research Unit in Emerging Zoonotic Infections (HPRU EZI) and the Centre of Excellence in Infectious Diseases Research (CEIDR), led by Professor Tom Solomon and Professor William Hope respectively, are working together to deliver an ambitious and innovative programme of work. CEIDR is a joint initiative between the Liverpool School of Tropical Medicine and the University of Liverpool.

Other key partners are Liverpool City Council and Malawi-Liverpool Wellcome Trust Clinical Research Programme.

The #Liverpool_Malawai_COVID19 research effort consists of:

• Clinical Characterisation and Biobanking
• Diagnostics
• Drug Discovery
• Viral Dynamics and Protective Immunity
• Pathogen Biology
• Epidemiology and Public Health Informatics
• Therapeutics, Early Phase Clinical Trials and Pharmacokinetics-Pharmacodynamics
• Vaccines
• Knowledge Mobilisation, Public and Community Involvement

For the full information and a breakdown of each topic, visit the CEIDR website here.